Category: Uncategorized
The Future of Pharma Field Force: Engaging healthcare providers through peer-to-peer education
With an unprecedented number of drug launches, the need for field force engagement has never been greater – but it’s the right type of engagement that matters. Field reps often perceive that providers want them to identify patient opportunities with new therapies, but a recent study by Bain & Company found that providers actually want their reps to provide trend data, patient support, and introductions to top experts in their field. […]
PlatformQ Health Presents Health Outcomes in Myelodysplastic Syndrome and Ulcerative Colitis at BMS Poster Day 2022
PlatformQ Health was invited to present at Bristol Myers Squibb private poster day. The posters present outcomes from two educational initiatives that show positive improvements in patient experience and clinical practice. CME Education Improves Clinical Practice for Treating Ulcerative Colitis Recent changes in understanding the drivers of ulcerative colitis have changed how the disease is […]
Global Biopharmaceutical Company Engages Field Force with PlatformQ Health’s National Broadcast Series
When a leading biopharmaceutical company began looking for an innovative approach for its speaker programs, they reached out to PlatformQ Health. […]
All Together Now for Cancer Clinical Trials
Inclusive clinical trials enable more patients to benefit from therapies that can improve their quality of life. However, an under-representation of racial and ethnic minority groups in clinical trials has been, and continues to be, a major issue within the U.S. healthcare system. “Disparities in clinical research participation are well documented and, like many other […]
PlatformQ Health’s Partnership with DBSA Yields Innovative Education in MDD
PlatformQ & our strategic partner The Depression and Bipolar Support Alliance are mounting a 2022 MDD summit providing CME accredited education initiatives. The summit will focus on treatment resistance therapies & how to support communities of color & LGBTQ+ youth who experience MDD. […]
Designing Successful Pharma Brand Launches
By applying adult learning principles, we’ve discovered that it’s possible to engage providers longer and help them retain more knowledge about a therapy. […]
A Spotlight on Rare Disease Products: From Launch & Beyond
Promoting new therapies in the rare disease space comes with unique challenges. There are many hurdles to gaining market adoption, particularly for those among the first to market in a disease state. […]
Go-to Market Strategies for a Successful Drug Launch: Best Practices for Engaging Providers and Patients
A strong pharma product launch can help bolster a drug’s performance over its lifecycle. Most new drugs continue with the revenue trajectory achieved at launch. An analysis by the Deloitte Center for Health Solution found roughly 80 percent of products that met or exceeded initial expectations continued their success rate in subsequent years. That’s why educating physicians quickly in the early months of a product launch delivers a notable advantage. […]
End of Year Infographic: A digital peer-to-peer education model designed to drive provider awareness, engagement and adoption
Early education of the marketplace is crucial for a successful pharmaceutical product launch. We’re pleased to share how our peer-to-peer education model drives more efficient provider education as well as alignment with the field force. Download the PDF Version: 2021-Infographic-DS Be sure to check out our other End of Year Infographics: Continuing Medical […]
It’s time to raise the bar on digital engagement
Peer-to-peer engagement can deliver more than mere video views – and can break through digital fatigue.
[…]
Driving HCP adoption: A brand manager’s guide to digital peer-to-peer engagement and education
Discover essential insights for how to drive a compelling digital engagement strategy. […]
SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes: Methodology and Monitoring Impact
In this CME offering presented by the Primary Care Network and Diabetes Series Live, Drs. Richard Beaser, Associate Professor of Medicine and Harvard Medical School and Nuha El Sayed, Director of International Programs at Joslin Diabetes Center introduce and educate viewers on a relatively new class of drugs to combat Type II Diabetes; the SGLT-2 […]
Pediatric Epilepsy: From early childhood through adolescence
In this CME offering from NeuroSeriesLive, Dr. Dennis Dlugos takes viewers through the current best practices for pediatric epilepsy. Using two case studies, Dr. Dlugos discusses diagnosis challenges and considerations, goals and concerns of medication treatments, and offers several non-medical treatment options. Dr. Dlugos, Professor of Neurology and Pediatrics at the Perelman School of Medicine […]